Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Swiss Re AG's Sloan Ratio for the quarter that ended in Dec. 2025 was 2.96%.
As of Dec. 2025, Swiss Re AG has a Sloan Ratio of 2.96%, indicating the company is in the safe zone and there is no funny business with accruals.
Swiss Re AG (OTCPK:SSREF) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Dec. 2025, Swiss Re AG has a Sloan Ratio of 2.96%, indicating the company is in the safe zone and there is no funny business with accruals.
Swiss Re AG Sloan Ratio % Related Terms
Swiss Re AG Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for Swiss Re AG's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Insurance - Reinsurance subindustry, Swiss Re AG's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Swiss Re AG Sloan Ratio % vs Insurance Industry
For the Insurance industry and Financial Services sector, Swiss Re AG's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Swiss Re AG's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Swiss Re AG's Sloan Ratio for the fiscal year that ended in Dec. 2025 is calculated as
For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data.
Swiss Re AG's Net Income for the trailing twelve months (TTM) ended in Dec. 2025 was 2596 (Jun. 2025 ) + 2144 (Dec. 2025 ) = $4,740 Mil.
Swiss Re AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was 1354 (Jun. 2025 ) + 1715 (Dec. 2025 ) = $3,069 Mil.
Swiss Re AG's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2025 was -1559 (Jun. 2025 ) + -741 (Dec. 2025 ) = $-2,300 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Swiss Re AG (SSREF) has a Sloan Ratio % of 2.96% as of Dec. 2025. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Swiss Re AG and its competitors.
Is Swiss Re AG's Sloan Ratio % too high?
Swiss Re AG's current Sloan Ratio % is 2.96%. Overall, Swiss Re AG has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Swiss Re AG's Sloan Ratio % compare to RGA and EG?
Swiss Re AG's Sloan Ratio % of 2.96% can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for an Insurance company?
A good Sloan Ratio % depends on the Insurance industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Swiss Re AG and its competitors. Swiss Re AG's current Sloan Ratio % is 2.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Swiss Re AG stock overvalued right now?
Based on GuruFocus' analysis, Swiss Re AG (SSREF) is currently considered Modestly Overvalued. The stock's GF Value™ is $130.89, compared to a current price of $158.02 — trading 20.7% above its estimated fair value. The current Sloan Ratio % is 2.96%. Swiss Re AG's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Swiss Re AG (SSREF), the current Sloan Ratio % is 2.96% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Swiss Re AG (SSREF) Overvalued in 2026?
Based on GuruFocus' analysis, Swiss Re AG stock appears to be overvalued.
The current stock price of $158.02 is trading 20.7% above its estimated GF Value™ of $130.89.
GuruFocus considers Swiss Re AG to be Modestly Overvalued.
Key valuation signals for SSREF:
Sloan Ratio %: 2.96%
GF Value™: $130.89 vs. price of $158.02 (20.7% above fair value)
No single metric tells the full story. See the SSREF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Swiss Re is a reinsurer that has three core divisions: P&C reinsurance, life and health reinsurance, and corporate solutions. Swiss Re was founded in 1863 when the general manager of Helvetia sought to stem the flow of reinsurance premiums outside Switzerland. Moritz Grossmann argued he could cut the premiums paid to foreign firms, still make a profit, and pay mid-single-digit dividends. Swiss Re is now the second-largest reinsurer in the world by market capitalization, with 80 offices around the world and approximately 15,000 employees. While the business did lose its way in the early part of the millennium, led by an investment banker who heavily invested in securitizations, Swiss Re has recently focused on establishing quality within its three core divisions.
67GF Score
Get the complete analysis for SSREF
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSREF has been successfully added to your 
